Medical device makers Abbott and Medtronic unveiled a global partnership that pairs Abbott's continuous glucose monitoring (CGM) sensors with the Medtronic insulin delivery system. The collaboration ...

Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with Type 2 diabetes in the U.S. and allowing it to connect with a ...

Medtronic has received a CE Mark for its Guardian Connect mobile continuous glucose monitor (CGM) and app. The company will begin selling the system in select countries in Europe, Asia, and Latin ...

Abbott and Medtronic are typically regarded as competitors, but the two medical device giants have recently decided to join forces. Last week, the two companies teamed up to collaborate on a ...

Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology ...

Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery systems ...

Forget the so-called 'Pulsed-Field Ablation Wars'—competition in the continuous glucose monitor (CGM) market is just as fierce. There have been several key approvals in the space, and on Monday, ...

Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps with ...

Abbott (NYSE:ABT) on Wednesday announced a global partnership to connect its continuous glucose monitoring system with Medtronic's (NYSE:MDT) automated insulin delivery (AID) and smart insulin pen ...

DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ ...